Decentralized clinical trial design using blood microsampling technology for serum bioanalysis

Alternatives to phlebotomy in clinical trials increase options for patients and clinicians by simplifying and increasing accessibility to clinical trials. The authors investigated the technical and logistical considerations of one technology compared with phlebotomy. Paired samples were collected from 16 donors via a second-generation serum gel microsampling device and conventional phlebotomy. Microsamples were subject to alternative sample handling conditions and were evaluated for quality, clinical testing and proteome profiling. Timely centrifugation of blood serum microsamples largely preserved analyte stability. Centrifugation timing of serum microsamples impacts the quality of specific clinical chemistry and protein biomarkers. Microsampling devices with remote centrifugation and refrigerated shipping can decrease patient burden, expand clinical trial populations and aid clinical decisions. Microsampling boosts #ClinicalTrials accessibility. This study shows collection of serum microsamples maintains a high degree of analyte stability for clinical chemistry and protein analytes. This technology may revolutionize clinical trials by expanding access. #Bioanalysis #HealthTech